All In Biotech

Drug Trial Radar · NCT06855264

A Cardiac Liability Study of Varegacestat in Healthy Participants

A Phase 1, Randomized, Single-Dose, Positive- and Placebo-Controlled, 3-Way Crossover Study to Evaluate the Effects of Varegacestat on Cardiac Repolarization in Healthy Participants

Last checked: Nov 20, 2026Latest source record: Sep 24, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

32

Actual

Start

Feb 24, 2025

Primary completion

Apr 8, 2025

Study completion May 6, 2025

Sponsor

Lead sponsor
Immunome, Inc.Industry
Sponsor type
Industry
First posted
Mar 3, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Crossover
Masking
Double (participant, investigator)
Primary purpose
Other
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 55 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This clinical study is designed to study the effect of a single dose of varegacestat on cardiac repolarization in healthy adult participants.

Conditions

  • Healthy Volunteer

Interventions

  • varegacestatDrug

    Single oral dose of varegacestat

  • PlaceboDrug

    Single oral dose of placebo

  • Moxifloxacin 400 mgDrug

    Single oral dose of moxifloxacin

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Placebo-corrected change from baseline QTc and varegacestat and its metabolite, AL102 MTB, plasma concentrationsTime frame: 24 hours

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Celerion

    Tempe, Arizona

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.